Acquisition by Albert Robichaud of 3375 shares of Sage Therapeutic subject to Rule 16b-3
SAGE Stock | USD 5.47 0.08 1.44% |
About 51% of Sage Therapeutic's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Sage Therapeutic suggests that some traders are interested. The current market sentiment, together with Sage Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Sage Therapeutic stock news signals to limit their universe of possible portfolio assets.
Sage |
Filed transaction by Sage Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Sage Therapeutic's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Sage Therapeutic's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Sage Therapeutic Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Sage Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sage Therapeutic Fundamental Analysis
We analyze Sage Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sage Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sage Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Sage Therapeutic is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Sage Therapeutic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sage Therapeutic stock to make a market-neutral strategy. Peer analysis of Sage Therapeutic could also be used in its relative valuation, which is a method of valuing Sage Therapeutic by comparing valuation metrics with similar companies.
Peers
Sage Therapeutic Related Equities
DMAC | DiaMedica Therapeutics | 8.64 | ||||
BDTX | Black Diamond | 3.11 | ||||
ARVN | Arvinas | 2.85 | ||||
PLRX | Pliant Therapeutics | 2.00 | ||||
STOK | Stoke Therapeutics | 1.68 | ||||
DAWN | Day One | 1.53 | ||||
BPMC | Blueprint Medicines | 1.35 | ||||
VTYX | Ventyx Biosciences | 1.13 | ||||
KRYS | Krystal Biotech | 0.26 | ||||
NUVL | Nuvalent | 0.08 | ||||
AKRO | Akero Therapeutics | 0.22 | ||||
ALNY | Alnylam Pharmaceuticals | 0.26 | ||||
IMCR | Immunocore Holdings | 0.27 | ||||
APLS | Apellis Pharmaceuticals | 0.62 | ||||
MDGL | Madrigal Pharmaceuticals | 0.98 | ||||
INCY | Incyte | 1.14 | ||||
TERN | Terns Pharmaceuticals | 1.58 | ||||
RLAY | Relay Therapeutics | 2.08 | ||||
AMLX | Amylyx Pharmaceuticals | 3.48 |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Managers Screen money managers from public funds and ETFs managed around the world |